Search
Take part in a research study
Latest news, posted 13 October 2017
Researchers at Aston University are inviting those that are sight impaired and severely impaired in the UK, to take part in a study investigating the impact of vision loss on diet and appetite.Participants will complete a telephone questionnaire, which w…
Charles Bonnet Q&A
Latest news, posted 23 October 2017
As part of our Charles Bonnet campaign, Dr John-Paul Taylor, Clinical Senior Lecturer and Consultant from the Newcastle University took part in a live Twitter question and answer session.If you were unable to join the session, please find the full Q&A; s…
Your questions answered
Latest news, posted 26 October 2017
On Monday we ran out of time to ask all of your questions as part of our Charles Bonnet Twitter Q&A.
Eye bank levels fall below level needed
Latest news, posted 30 October 2017
NHS Blood and Transplant (NHSBT) has revealed that its eye banks are 21% below the level needed to supply hospitals, leading to delays in cornea transplant operations.At the end of September, there were 278 corneas in the service’s Manchester and Bristol…
Simplyhealth funds counselling service for people with sight loss
Latest news, posted 31 October 2017
Simplyhealth has donated £30,000 to the Macular Society to help people with macular disease gain access to vital counselling services.The Macular Society, the national sight loss charity, offers free telephone counselling by accredited counsellors which …
Drug companies threaten legal fight over cheaper drug
Latest news, posted 1 November 2017
Health chiefs face a legal fight over plans to give a cheap drug to patients with wet age-related macular degeneration (AMD).
Eylea approved for myopic CNV patients
Latest news, posted 1 November 2017
The National Institute of Health and Care Excellence (NICE) has recommended the use of Eylea® on adults for treating visual impairment due to myopic chorodial neovascularisation (CNV).Pathological myopia, also known as severe near sightedness, affects 3%…
Do you want a place in the London Marathon?
Latest news, posted 8 November 2017
Have you always wanted to run the London Marathon but struggled to get a place?Now could be your chance to do just that, while raising vital funds for people with macular disease.The Macular Society has a coveted place in next year’s race and is calling …
FDA investigate potential Stargardt treatment
Latest news, posted 13 November 2017
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a drug to help treat Stargardt disease, according to Lin BioScience.The drug, known as LBS-008, is designed to prevent the build-up of a toxin in the eye called lipofuscin…
Coming up in winter’s Sideview
Latest news, posted 14 November 2017
The latest issue of Sideview magazine will be sent out to 22,000 Macular Society members in late November.